About
Aisling Capital is a leading institutional investment firm based in New York, USA. Established in 2000 with the aim of supporting the development and commercialization of important and innovative healthcare products, services, and technologies, Aisling Capital has built a notable portfolio that includes companies in the health tech and biotechnology sectors. Known for its expertise and a team with over 150 years of combined experience in the healthcare industry, Aisling Capital prides itself on a track record of successful investments and capital returns. They have raised over $1.8 billion in committed capital across four funds, investing in both private and public companies with a wide variety of investment structures. Aisling Capital has made 106 investments to date and takes an active approach, working closely with portfolio companies.